These results indicate that PDE5 inhibitors provide cardioprotection against DCM by inhibiting NLRP3 inflammasome-mediated pyroptosis; however, direct evidence is still lacking. This evidence concerns the gene NLRP3 and familial dilated cardiomyopathy.